| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.
|
N Engl J Med
|
2002
|
18.61
|
|
2
|
Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.
|
N Engl J Med
|
2002
|
7.66
|
|
3
|
Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.
|
N Engl J Med
|
2010
|
5.17
|
|
4
|
Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31.
|
J Clin Oncol
|
2011
|
4.81
|
|
5
|
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
|
J Clin Oncol
|
2012
|
4.57
|
|
6
|
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
|
J Clin Oncol
|
2009
|
3.99
|
|
7
|
Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
|
Lancet
|
2004
|
3.98
|
|
8
|
Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
|
J Clin Oncol
|
2004
|
3.82
|
|
9
|
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials.
|
J Clin Oncol
|
2006
|
2.83
|
|
10
|
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
|
J Clin Oncol
|
2008
|
2.55
|
|
11
|
Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
|
Cancer
|
2003
|
2.37
|
|
12
|
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.
|
J Natl Cancer Inst
|
2013
|
2.28
|
|
13
|
Breast cancer adjuvant therapy: time to consider its time-dependent effects.
|
J Clin Oncol
|
2011
|
2.16
|
|
14
|
A new generalization of Weibull distribution with application to a breast cancer data set.
|
Stat Med
|
2009
|
2.06
|
|
15
|
Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials.
|
J Natl Cancer Inst
|
2004
|
1.88
|
|
16
|
Population-based study of competing mortality in head and neck cancer.
|
J Clin Oncol
|
2011
|
1.82
|
|
17
|
Amenorrhea from breast cancer therapy--not a matter of dose.
|
N Engl J Med
|
2010
|
1.40
|
|
18
|
Regression on quantile residual life.
|
Biometrics
|
2009
|
1.25
|
|
19
|
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.
|
J Clin Oncol
|
2009
|
1.25
|
|
20
|
Predictors of competing mortality in early breast cancer.
|
Cancer
|
2010
|
1.08
|
|
21
|
Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity.
|
Oral Oncol
|
2007
|
1.02
|
|
22
|
Rank tests for clustered survival data.
|
Lifetime Data Anal
|
2003
|
1.01
|
|
23
|
Median tests for censored survival data; a contingency table approach.
|
Biometrics
|
2012
|
0.97
|
|
24
|
Akt phosphorylation at Ser473 predicts benefit of paclitaxel chemotherapy in node-positive breast cancer.
|
J Clin Oncol
|
2010
|
0.96
|
|
25
|
Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of Parkinsonism phenotypes in zebrafish models.
|
Neurobiol Dis
|
2011
|
0.94
|
|
26
|
Pitfalls of using composite primary end points in the presence of competing risks.
|
J Clin Oncol
|
2010
|
0.92
|
|
27
|
Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
|
J Clin Oncol
|
2006
|
0.89
|
|
28
|
Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
|
Cancer
|
2003
|
0.89
|
|
29
|
An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration.
|
J Biol Chem
|
2013
|
0.85
|
|
30
|
Empirical likelihood ratio test for median and mean residual lifetime.
|
Stat Med
|
2010
|
0.84
|
|
31
|
NSABP B-42: a clinical trial to determine the efficacy of five years of letrozole compared with placebo in patients completing five years of hormonal therapy consisting of an aromatase inhibitor (AI) or tamoxifen followed by an AI in prolonging disease-free survival in postmenopausal women with hormone receptor-positive breast cancer.
|
Clin Breast Cancer
|
2006
|
0.83
|
|
32
|
Constrained parametric model for simultaneous inference of two cumulative incidence functions.
|
Biom J
|
2012
|
0.80
|
|
33
|
Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy.
|
Oral Oncol
|
2005
|
0.79
|
|
34
|
Reporting of cause-specific treatment effects in cancer clinical trials with competing risks: a systematic review.
|
Contemp Clin Trials
|
2012
|
0.77
|
|
35
|
Low-Fidelity Haptic Simulation Versus Mental Imagery Training for Epidural Anesthesia Technical Achievement in Novice Anesthesiology Residents: A Randomized Comparative Study.
|
Anesth Analg
|
2016
|
0.75
|
|
36
|
The Influence of Knee Pain Location on Symptoms, Functional Status, and Knee-related Quality of Life in Older Adults With Chronic Knee Pain: Data From the Osteoarthritis Initiative.
|
Clin J Pain
|
2016
|
0.75
|
|
37
|
Stationary versus agitated storage of whole blood during acute normovolemic hemodilution.
|
Anesth Analg
|
2014
|
0.75
|
|
38
|
Variable selection in subdistribution hazard frailty models with competing risks data.
|
Stat Med
|
2014
|
0.75
|
|
39
|
Reply to V. Pitini et al.
|
J Clin Oncol
|
2013
|
0.75
|
|
40
|
Bayesian nonparametric inference on quantile residual life function: Application to breast cancer data.
|
Stat Med
|
2012
|
0.75
|
|
41
|
Censored quantile regression for residual lifetimes.
|
Lifetime Data Anal
|
2011
|
0.75
|